Pure Bioscience (PURE)
OTHER OTC:PURE
Holding PURE?
Track your performance easily

Pure Bioscience (PURE) Financial Statements

40 Followers

Pure Bioscience Financial Overview

Pure Bioscience's market cap is currently ―. The company's EPS TTM is $-0.03; its P/E ratio is -4.00; Pure Bioscience is scheduled to report earnings on December 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Apr 23
Income Statement-
Total Revenue$ 474.00K$ 441.00K$ 326.00K$ 722.00K$ 407.00K
Gross Profit$ 275.00K$ 258.00K$ 177.00K$ 442.00K$ 196.00K
EBIT$ -756.00K$ -816.00K$ -964.00K$ -711.00K$ -874.00K
EBITDA$ -718.00K$ -780.00K$ -927.00K$ -674.00K$ -839.00K
Net Income Common Stockholders$ -756.00K$ -857.00K$ -1.00M$ -735.00K$ -876.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 349.00K$ 442.00K$ 557.00K$ 1.44M$ 781.00K
Total Assets$ 818.00K$ 920.00K$ 1.09M$ 2.25M$ 1.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -349.00K$ -442.00K$ -557.00K$ -1.44M$ -781.00K
Total Liabilities$ 3.68M$ 666.00K$ 2.41M$ 2.63M$ 569.00K
Stockholders Equity$ -2.86M$ -2.15M$ -1.32M$ -383.00K$ 1.25M
Cash Flow-
Free Cash Flow$ -593.00K$ -615.00K$ -883.00K$ -440.00K$ -704.00K
Operating Cash Flow$ -593.00K$ -615.00K$ -883.00K$ -440.00K$ -665.00K
Investing Cash Flow----$ -39.00K
Financing Cash Flow$ 500.00K$ 500.00K-$ 785.00K-
Currency in USD

Pure Bioscience Earnings and Revenue History

Pure Bioscience Debt to Assets

Pure Bioscience Cash Flow

Pure Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis